The status of functional exercise compliance in patients with Parkinson’s disease has received extensive attention from researchers at home and abroad. Often, people with Parkinson’s disease need to perform functional exercises to alleviate symptoms of the disease and improve their quality of life. However, studies have found that Parkinson’s patients have varying degrees of problems in their compliance with functional exercise. Especially in the maintenance of long-term exercise, patients often experience a decline in compliance. This will not only affect the recovery and quality of life of patients but also increase the economic burden on patients’ families and society.
There are some common characteristics of functional exercise compliance in patients with Parkinson’s disease. On the one hand, patients recognized the importance and effect of functional exercise and had a higher willingness to exercise. However, on the other hand, due to the characteristics of Parkinson’s disease itself, patients often have problems with exercise ability and endurance, which affects their long-term exercise compliance.
Author(s) Details:
He Huang
Independent Researcher, 2308 Ruth Ct, Rowland Heights, CA 91748, Los Angeles, USA.
Recent Global Research Developments in Parkinson’s Disease and Its Management: A Comprehensive Overview
Global Prevalence of PD:
- According to the World Health Organization (WHO), the number of individuals with PD globally surpassed 8.5 million in 2019, a significant rise from 6.1 million cases reported in 2016 and 2.5 million in 1990 [1].
- Projections suggest that the global burden of PD may exceed 17 million cases by 2040 [1].
National Efforts in Thailand:
- Thailand, like many low-to-middle income countries, faces challenges in managing the rising prevalence of PD.
- A proactive approach is crucial, as early identification allows timely therapeutic interventions.
- The “Parkinson’s disease risk survey” (TCTR20231025005) aims to evaluate a digital population screening platform for identifying undiagnosed PD cases in the Thai population [1].
Digital Health Technologies:
- Digital health technologies play a pivotal role in early diagnosis and intervention.
- Efforts include national digital screening and lifestyle interventions (such as “eat, move, sleep”) to prevent or slow the rise of non-communicable diseases, including PD [1].
Comprehensive Overviews:
- For comprehensive overviews, consider exploring the following research articles:
- “Global Trends in the Incidence, Prevalence, and Years Lived With PD” provides insights at global, regional, and national levels [2].
- “The Management of Parkinson’s Disease: An Overview of the Current Advancements in Drug Delivery Systems” discusses promising features and drawbacks of drug delivery systems [3].
- “Epidemiology of Parkinson’s Disease: An Update” covers PD pathophysiology, risk factors, and clinical implications [4].
- “Six Action Steps to Address Global Disparities in Parkinson Disease” highlights the increasing burden of PD worldwide [5].
References
- Bhidayasiri R, Sringean J, Phumphid S, Anan C, Thanawattano C, Deoisres S, Panyakaew P, Phokaewvarangkul O, Maytharakcheep S, Buranasrikul V, Prasertpan T, Khontong R, Jagota P, Chaisongkram A, Jankate W, Meesri J, Chantadunga A, Rattanajun P, Sutaphan P, Jitpugdee W, Chokpatcharavate M, Avihingsanon Y, Sittipunt C, Sittitrai W, Boonrach G, Phonsrithong A, Suvanprakorn P, Vichitcholchai J and Bunnag T (2024) The rise of Parkinson’s disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and “eat, move, sleep” lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand. Front. Neurol. 15:1386608. doi: 10.3389/fneur.2024.1386608
- Ou, Z., Pan, J., Tang, S., Duan, D., Yu, D., Nong, H., & Wang, Z. (2021). Global trends in the incidence, prevalence, and years lived with disability of Parkinson’s disease in 204 countries/territories from 1990 to 2019. Frontiers in public health, 9, 776847.
- Nakmode, D. D., Day, C. M., Song, Y., & Garg, S. (2023). The management of Parkinson’s disease: An overview of the current advancements in drug delivery systems. Pharmaceutics, 15(5), 1503.
- Deliz, J.R., Tanner, C.M. & Gonzalez-Latapi, P. Epidemiology of Parkinson’s Disease: An Update. Curr Neurol Neurosci Rep 24, 163–179 (2024). https://doi.org/10.1007/s11910-024-01339-w
- Schiess N, Cataldi R, Okun MS, et al. Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority. JAMA Neurol. 2022;79(9):929–936. doi:10.1001/jamaneurol.2022.1783